Nicholas J. Ashton
Alzheimer's Association(US)British Museum(GB)University of Arizona(US)King's College London(GB)Neurosciences Institute(US)South London and Maudsley NHS Foundation Trust(GB)University of Utah(US)Manchester Academic Health Science Centre(GB)Stavanger University Hospital(NO)Jordan Hospital(JO)Sahlgrenska University Hospital(SE)Banner Health(US)University of Manchester(GB)National Institute for Health and Care Excellence(GB)Centre for Mental Health(GB)National Institute for Health Research(GB)Dana-Farber Cancer Institute(US)NIHR Maudsley Dementia Biomedical Research Unit(GB)Banner Sun Health Research Institute(US)BioFire Diagnostics (United States)(US)Banner Alzheimer’s InstituteNIHR Maudsley Biomedical Research CentreUniversity of Gothenburg(SE)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Neuroinflammation and Neurodegeneration Mechanisms, Neurological Disease Mechanisms and Treatments, Functional Brain Connectivity Studies
Most-Cited Works
- → Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts(2020)1,309 cited
- → The Selaginella Genome Identifies Genetic Changes Associated with the Evolution of Vascular Plants(2011)884 cited
- → Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology(2021)683 cited
- → Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology(2024)649 cited
- → Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum(2021)586 cited
- → Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease(2021)545 cited